Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 7/1/08 → 11/30/10 |
Financiación
- Elan Pharmaceuticals PLC: 128.300,00 US$
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in patients with mild to moderate Alzheimer's Disease who are Apolopoprotien E4 epsilon4 Carriers
- Jicha, Gregory (PI)
- Cambi, Franca (CoI)
- Cooper, Gregory (CoI)
- Fee, Dominic (CoI)
- Markesbery, William (CoI)
- Schmitt, Frederick (CoI)
- Smith, Charles (CoI)